Decoy Therapeutics Inc.
DCOY·NasdaqCM·Healthcare
1.1400+0.0300 (+2.70%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Previous close1.1100
Open1.1450
Day range1.13001.1500
52-week range0.900039.7200
Off day high−0.87%
Off 52-week high−97.13%
Volume16.60K
Avg. volume (3M)2.16M
Market cap2.72M
EPS (TTM)12.74
Forward P/E-0.14
P/E ratio (TTM)0.09
Dividend yield—
Beta (5Y)0.74
Shares outstanding2.39M
Short interest4.10% of float
Earnings date—
Analyst target3.0000
Profit margin0.00%
Against its peers
Compare in full ›| DCOY | REVB | INDP | DTC.CN | AKTX | IMM.L | |
|---|---|---|---|---|---|---|
| Market cap | 2.72M | 2.34M | 439.70M | 25.50M | 21.23M | 20.26M |
| P/E (TTM) | 0.1 | 0.1 | — | — | — | — |
| Forward P/E | -0.1 | -0.2 | -2.4 | — | -1.1 | 0.0 |
| Price/book | 0.1 | 0.2 | 38.8 | 7.3 | 0.9 | 10.8 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −96.63% | −85.44% | +23.13% | −61.05% | −62.30% | −69.00% |
| Today | +2.70% | −7.05% | +1.85% | −1.47% | +13.98% | −0.46% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All DCOY news ›Decoy Therapeutics Provides Third Quarter 2026 Business Update
Lead pan-coronavirus program expected to file CTA/IND in 2H 2027 Optimized lead candidate shows potential for once-weekly dosing in preclinical studies Cash on balance sheet of $8.1 million at September 30, 2026 Third Quarter 2026…
From the 4Search news index, newest first.
In the news
3mentions in 30 days
3with it in the headline
Positivesentiment
Mentioned with
People in the coverage
Most coverage from
- globenewswire.com1
- manilatimes.net1
- stocktitan.net1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 3 articles, not a forecast.